- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Selumetinib
Total 112 results
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingLow Grade Glioma | Recurrent Visual Pathway Glioma | Refractory Visual Pathway Glioma | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Neurofibromatosis Type 1 | Refractory Neurofibromatosis Type 1United States
-
AstraZenecaCompletedMelanoma | Breast Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Gastroesophageal CancerUnited States
-
Haihe Biopharma Co., Ltd.UnknownNegative T790M Mutation and Met AmplificationChina
-
Merck Sharp & Dohme LLCCompletedAdvanced/Metastatic Solid TumorsUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Gland Carcinoma | Stage I Thyroid Gland Papillary Carcinoma | Stage II Thyroid Gland Papillary Carcinoma | Stage III Thyroid Gland Papillary Carcinoma | Stage IV Thyroid Gland Papillary CarcinomaUnited States, Canada
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingNon-small Cell Lung CancerUnited States
-
University of ChicagoRecruitingChronic Myeloid Leukemia | MyelofibrosesUnited States
-
National Cancer Institute (NCI)TerminatedNon-Metastatic Adenocarcinoma of the RectumUnited States
-
AstraZenecaCompletedNon Small Cell Lung CancerUnited States, Belgium, France, Italy, Spain, Canada, Brazil, Hungary, Peru, Czechia, Bulgaria, Mexico
-
Samsung Medical CenterCompleted
-
AstraZenecaCompletedMelanomaSweden, United States, Brazil, Czech Republic, France, Spain, United Kingdom, Germany, Norway, Hungary, Netherlands, Switzerland
-
University Health Network, TorontoActive, not recruitingGallbladder Carcinoma | Biliary Tract CarcinomaCanada
-
AstraZenecaCompletedUveal Melanoma | MetastaticUnited States, Czech Republic, Spain, United Kingdom, Germany, Canada, Israel, Netherlands, Belgium, France, Finland
-
M.D. Anderson Cancer CenterAstraZenecaActive, not recruitingMalignant Neoplasms of Female Genital Organs | Malignant Neoplasm of Breast | Malignant Neoplasms of Thyroid and Other Endocrine Glands | Malignant Neoplasms of Digestive Organs | Malignant Neoplasms of Male Genital OrgansUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; AstraZenecaTerminated
-
AstraZenecaCompletedColorectal CancerUnited States
-
The Netherlands Cancer InstituteAstraZeneca; Boehringer IngelheimUnknownGastrointestinal Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic NeoplasmsNetherlands
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
Canadian Cancer Trials GroupAstraZenecaCompleted
-
Sarcoma Alliance for Research through CollaborationUnited States Department of Defense; AstraZenecaCompletedNeurofibromatosis 1 | Malignant Peripheral Nerve Sheath TumorsUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Poland, France, Germany, Brazil, Hungary, Netherlands, Bulgaria
-
AstraZenecaTerminatedInoperable Locally Advanced or Metastatic Biliary Tract CancerJapan
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland, Belgium
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
AstraZenecaQuintiles, Inc.CompletedLocally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)United States
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerSpain, United States, Canada, France, United Kingdom
-
University College, LondonAstraZenecaCompletedCholangiocarcinoma | Biliary Tract Neoplasms | Gallbladder NeoplasmsUnited Kingdom
-
National Cancer Institute (NCI)CompletedAdult Solid NeoplasmUnited States
-
Canadian Cancer Trials GroupAstraZenecaCompletedNon Small Cell Lung CancerCanada
-
University of BirminghamAstraZeneca; Cancer Research UKTerminatedAcute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, Adult | Acute Lymphoblastic Leukemia RecurrentUnited Kingdom, Denmark, Netherlands
-
University of CologneCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Mucosal MelanomaUnited States
-
OHSU Knight Cancer InstituteAstraZeneca; Oregon Health and Science UniversityCompletedStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
University of BirminghamPfizer; AstraZeneca; Mirati Therapeutics Inc.; Cancer Research UK; Experimental Cancer...Active, not recruitingAdenocarcinoma | Carcinoma, Squamous Cell | Non-Small Cell Lung CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent WHO Grade 2 Glioma | Recurrent Low Grade Astrocytoma | Refractory Low Grade Astrocytoma | Refractory Low Grade Glioma | Refractory WHO Grade 1 GliomaUnited States, Canada
-
UNICANCERAstraZeneca; Intergroupe Francophone de Cancerologie Thoracique; Fondation ARCCompletedNon-small Cell Lung Cancer MetastaticFrance
-
Russian Academy of Medical SciencesRussian Society of Clinical OncologyUnknownTriple Negative Breast Cancer
-
National Cancer Institute (NCI)National Comprehensive Cancer NetworkCompletedRecurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue SarcomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoma, Non-Small-Cell Lung | Carcinoma, Small Cell Lung | Carcinoma, ThymicUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCL Cancer Stage IIIB IVUnited Kingdom
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRecurrent Thyroid Gland Carcinoma | Poorly Differentiated Thyroid Gland Carcinoma | Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 | Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IVA Thyroid Gland Papillary Carcinoma AJCC... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingLow Grade Glioma | Low Grade Astrocytoma | Metastatic Low Grade Astrocytoma | Metastatic Low Grade GliomaUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)RecruitingNeurofibromatosis Type 1 | Low Grade Glioma | Visual Pathway GliomaUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingStage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Recurrent Colorectal Carcinoma | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer AJCC v7 | Solid NeoplasmUnited States, Canada
-
AstraZenecaCompletedTo Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male VolunteersSolid TumoursUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial CarcinomaUnited States, Puerto Rico